Karlsson J

ORCID: 0000-0002-6457-0817 · 2 papers in corpus
2020
Cancer biotherapy & radiopharmaceuticals ·doi:10.1089/cbr.2020.3568

Targeted α therapy (TAT) offers the potential for the targeted delivery of potent α-particle-emitting radionuclides that emit high linear energy transfer radiation. This leads to a densely ionizing radiation track over a short path. Localiz…

2019
JBJS reviews ·doi:10.2106/jbjs.rvw.18.00150

BackgroundThe minimum clinically important difference (MCID) was developed to ascertain the smallest change in an outcome that patients perceive as beneficial. The objectives of the present review were (1) to compare the MCIDs for pain asse…